BIOBOHEMIA
Pipeline
This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use.
I accept
Close

Patents and Trademark

2017
US patent
№09844586
"Method for producing an antitumoral vaccine based on surface endothelial cell antigens"
See patent
2015
European patent
№2140873
"Method for producing an antitumoral vaccine based on surface endothelial cell antigens"
See patent
2013
Korean patent
№10-1290641
"Method for producing an antitumoral vaccine based on surface endothelial cell antigens"
See patent
2013
Japanese patent
№ 5172864
"Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy"
See patent
2013
Japanese patent
№5154641
"Method for producing an antitumoral vaccine based on surface endothelial cell antigens"
See patent
2012
Chinese patent
№ 101636174
"Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy"
See patent
2009
Eurasian patent
№011421
"Method for preparing the tumor vaccine"
See patent
2007
Eurasian patent
№009326
"Method for testing quality of cell culture"
See patent
2007
Eurasian patent
№009327
"Method for producing an antitumoral vaccine based on surface endothelial cell antigens"
See patent
2007
Eurasian patent
№009325
"Antitumor vaccine, method for preparing thereof and method for using antitumor immunotherapy"
See patent
Trademark
Trademark
2017
US Serial Number: 79199387
The trademark SANTAVAC™ was registered in International Register of Marks maintained under the Madrid Agreement and Protocol.
Designations under Madrid protocol: USA, European Union, Japan, Republic of Korea, China
See trademark